Jake Chervinsky, CEO of the Hyperliquid Policy Center, has criticized the CME Group's lawsuit against the U.S. Commodity Futures Trading Commission (CFTC), calling it a "shocking misjudgment" and an "unnecessary misstep." Chervinsky argues that the CME Group, which dominates 92% of the U.S. derivatives market, is acting as a "monopolistic vested interest" fearful of competition. The lawsuit comes as U.S. regulators have recently opened a compliance pathway for perpetual contracts, a move that could increase market choice and reduce costs for U.S. users who have historically turned to overseas markets for such products. Chervinsky highlights that the CME's legal action aims to "shut down this channel," potentially stifling competition and innovation in the derivatives market.